Lin BioScience, Inc. (6696) - Financials, balance sheet (annual)

150.5 TWD

Last update Aug 1, 1:25 PM CST

Market closed

Day range

150.5

148.5

154

Previous close

150.5

Open

149.5

Access this stock data via API

Lin BioScience, Inc.

150.50

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	5.5B	3.6B	1.9B	923.2M
Current assets	5.4B	3.4B	1.7B	819.5M
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	1.5B	3.3B	1.6B	806.8M
Other short term investments	3.7B	—	—	—
Accounts receivable	—	—	—	—
Other receivables	18.9M	25.2M	69K	1.5M
Inventory	—	—	—	—
Prepaid assets	123.3M	137.7M	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	352K	3K	27.0M	11.2M
Non current assets	175.7M	172.5M	179.7M	103.7M
Properties	50.7M	58.9M	65.9M	5.4M
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	1.8M	183K	949K	0
Leases	—	—	—	—
Accumulated depreciation	—	—	—	—
Goodwill	118.4M	108.9M	108.9M	97.1M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	—	—	—
Investments and advances	—	—	—	—
Other non current assets	—	—	—	—
Total liabilities	173.2M	167.7M	116.1M	470.3M
Current liabilities	155.3M	138.7M	79.9M	470.3M
Accounts payable	—	—	—	—
Accrued expenses	—	—	—	—
Short term debt	16.1M	13.8M	10.3M	2.2M
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	—	—	—	—
Other current liabilities	7.8M	1.8M	7.1M	3.9M
Non current liabilities	17.9M	29.0M	36.2M	0
Long term provisions	—	—	—	—
Long term debt	17.9M	29.0M	36.2M	0
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	—	—
Shareholders equity
Common stock	786.7M	785.6M	724.0M	691.3M
Retained earnings	-2.9B	-2.2B	-1.5B	-1.2B
Other shareholders equity	—	—	—	—
Total shareholders equity	5.4B	3.4B	1.7B	453.0M
Additional paid in capital	4.8B	3.5B	1.9B	1.0B
Treasury stock	—	—	—	—
Minority interest	2.5B	1.3B	501.9M	-88.6M